PA arc
PA arc PA Consulting Group is a leading global management, systems and technology consulting firm. Committed to innovation, responsive to our clients' needs, and focused on delivery of value, PA designs and delivers innovative solutions to complex business issues.

Regulators

Quality systems: effective delivery of compliance

Effective regulatory quality and compliance processes are vital to maintaining shareholder value. Commercial risks escalate as strained infrastructures struggle to assure compliance. Controlling these profound commercial risks require effective initiatives to keep pace with regulatory scrutiny.

PA helps clients implement and deliver strategies and initiatives for pharmaceutical, medical device, immune diagnostics and biotechnology organisations, including:

  • deliver and implement corporate quality system strategy
  • catalogue and resolve compliance exposure and business risks
  • manage FDA 483 / Warning Letter Remediation
  • quality system, IP and operations M&A due diligence
  • pharmaceutical process and PAT development in dedicated GMP / GLP facilities.
  • Lean Six Sigma optimisation and process quantification
  • optimise quality system and CAPA system performance
  • independent quality management system IT Implementation and assessment
  • align QMS, ESP, MES, MCP with QSR, ISO13485, 21 CFR Part 11,  210,  211,
  • commercial and healthcare personalised medicine implementation

Further information

For further information please e-mail: healthcare@paconsulting.com

Sign in |  Register
Advanced search
Site map    Help   
 
Locations  
 

Healthcare key visual

Leveraging compliance to accelerate programmes

PA's current experience in: affecting compliance dynamics to improve results; re-establishing control over your programme; and compliant product and process development.

For further details click on the relevant link below.

 

 

* Return to PA's life sciences and healthcare portal Home page

* Compliance and effectiveness - Two sides of the marketing coin

* A better approach to global regulatory control

* Leveraging compliance to accelerate programmes

* Risk-based programme management

* Proactive compliance in pharmaceutical marketing

* Medicines Control Agency: Implementing major strategic change through groundbreaking outsourcing

* PA's approach to 21CFR11 compliance